EUVIMEDEUVIMED entdecken
Multizentrische StudieFall-Kontroll-StudieOpen Access · CC BY 4.0

Inhibin B and AMH for Diagnosis of Hypogonadotropic Hypogonadism in Boys Under 1 Year of Age: A Case-control Study

Tifenn Gueguen, Laetitia Martinerie, Sarah Castets, Vanessa Menut, Carine Villanueva, Anne Sophie Lambert, Kevin Perge iD, Natacha Bouhours-Nouet, Lucie Levaillant, Tristan Avril, Dominique Simon, Marc de Kerdanet und 6 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.11.2025 · 110 (12) · e4119-e4128

DOI: 10.1210/clinem/dgaf219 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 07.04.2025. Verfasst von Tifenn Gueguen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, University Hospital, Angers 49100, France. Hauptthemen laut MEDLINE: Inhibins, Hypogonadism, Anti-Mullerian Hormone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Congenital hypogonadotropic hypogonadism (CHH) in infant boys is a rare disorder that can manifest as micropenis and/or cryptorchidism. Mini-puberty is considered a window of opportunity for CHH diagnosis and treatment. The lack of testosterone (T) elevation during this period is the gold standard for CHH diagnosis, but hormonal evaluation is not always available at this time.

Objectives

The aim was to compare inhibin B (INHB), anti-Müllerian hormone (AMH), T, LH, and FSH between infant boys (1 to 365 days) with micropenis and/or cryptorchidism due to isolated CHH (iCHH), CHH as part of combined pituitary hormone deficiency (CPHD), or of idiopathic origin (controls) and to determine discriminating cutoffs for CHH diagnosis based on sensitivity (Se) and specificity (Sp).

Methods

This multicenter study from 7 University Hospitals in France included 138 boys aged 0 to 12 months (58 with iCHH, including 28 with a positive molecular diagnosis, 32 with CPHD, and 48 controls). Four periods of interest were studied: between 1 to 4 days, 15 to 65 days (early mini-puberty, corresponding to the T peak), 66 to 179 days (late mini-puberty), and 180 to 365 days (post mini-puberty).

Results

Out of mini-puberty, the best-discriminating hormones were INHB between 1 to 4 days (Se/Sp 100%/75% at 150 pg/mL and 89%/100% at 85 pg/mL) and INHB and AMH after 180 days (INHB: Se/Sp 100%/100% at 100 pg/mL; AMH: Se/Sp 100%/92% at 600 pmol/L, and 75%/100% at 370 pmol/L). INHB and/or AMH discriminating performances were good (area under the receiver operating characteristic curve ≥ 0.95) across all 4 periods.

Conclusion

Inhibin B and/or AMH can be used to diagnose CHH in boys < 1 year of age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InhibinsHypogonadismAnti-Mullerian HormoneHumansMaleInfantCase-Control StudiesInfant, NewbornSensitivity and SpecificityTestosteroneCryptorchidismLuteinizing HormoneBiomarkersFollicle Stimulating Hormone

Stichwörter der Autor:innen

AMHhypogonadotropic hypogonadisminfantinhibin Bmaletestosterone

Substanzen

Inhibinsinhibin BAnti-Mullerian HormoneTestosteroneLuteinizing HormoneBiomarkersFollicle Stimulating Hormone

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, University Hospital, Angers 49100, France.
  • Reference Center for Rare Pituitary Diseases, CHU Angers, Angers 49100, France.
  • Pediatric Endocrinology Department, CHU Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris 75019, France.
  • Reference Center for Rare Disease CRMR de la Croissance et du Développement, CHU Robert Debré, Paris 75019, France.
  • Université Paris Cité, Paris 75013, France.
  • Department of Pediatric Endocrinology, Assistance Publique-Hôpitaux de Marseille, Marseille 13005, France.

ORCID-Profile: Kevin Perge, Najiba Lahlou, Regis Coutant

Zitieren

APA

Gueguen, T., Martinerie, L., Castets, S., Menut, V., Villanueva, C., Lambert, A. S., Perge, K., Bouhours-Nouet, N., Levaillant, L., Avril, T., Simon, D., de Kerdanet, M., Lahlou, N., Baron, S., Reynaud, R., Nicolino, M., Bouvattier, C., & Coutant, R. (2025). Inhibin B and AMH for Diagnosis of Hypogonadotropic Hypogonadism in Boys Under 1 Year of Age: A Case-control Study. The Journal of Clinical Endocrinology & Metabolism, 110(12), e4119-e4128. https://doi.org/10.1210/clinem/dgaf219

Vancouver

Gueguen T, Martinerie L, Castets S, Menut V, Villanueva C, Lambert AS, et al. Inhibin B and AMH for Diagnosis of Hypogonadotropic Hypogonadism in Boys Under 1 Year of Age: A Case-control Study. The Journal of Clinical Endocrinology & Metabolism. 2025;110(12):e4119-e4128. doi:10.1210/clinem/dgaf219

BibTeX
@article{Gueguen2025,
  author = {Gueguen, Tifenn and Martinerie, Laetitia and Castets, Sarah and Menut, Vanessa and Villanueva, Carine and Lambert, Anne Sophie and Perge, Kevin and Bouhours-Nouet, Natacha and Levaillant, Lucie and Avril, Tristan and Simon, Dominique and de Kerdanet, Marc and Lahlou, Najiba and Baron, Sabine and Reynaud, Rachel and Nicolino, Marc and Bouvattier, Claire and Coutant, Regis},
  title = {Inhibin B and AMH for Diagnosis of Hypogonadotropic Hypogonadism in Boys Under 1 Year of Age: A Case-control Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {12},
  pages = {e4119--e4128},
  doi = {10.1210/clinem/dgaf219}
}
Kostenlos starten →